Lobbying client
AMERICAN PHARMACEUTICAL SERVICES, INC.
Manufacture Active Pharmaceutical Ingredients
Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$120,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2022
Filings
9 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2022
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2022
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2021
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2021
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2021
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
|
1st Quarter - Report 1st Quarter 2021
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2020
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | $50,000 reported |
|
3rd Quarter - Amendment 3rd Quarter 2020
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | $20,000 reported |
|
Registration 3rd Quarter 2020
|
CORNERSTONE GOVERNMENT AFFAIRS, INC. | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 8 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 4 |
| Budget/Appropriations | BUD | 4 |
| Defense | DEF | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.